Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01124045 · ClinicalTrials.gov registry record · Phase 3
Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery
A Phase 3 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 80
- Enrollment target
NCT01124045 is a Phase 3 study that has completed, run by Alcon Research. The registered enrollment target is 80 participants.
The verdict
NCT01124045, a Phase 3 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 80 participants
- Enrollment target
Study Summary
The primary objective of this study was to compare the safety and efficacy of Durezol™ compared to Pred Forte™ for the treatment of inflammation following cataract surgery in a pediatric population 0 to 3 years of age.
Interventions
- DRUG Difluprednate ophthalmic emulsion, 0.05%
- DRUG Prednisolone acetate ophthalmic suspension, 1.0%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01124045
The ClinicalTrials.gov registry entry for NCT01124045 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Difluprednate ophthalmic emulsion, 0.05% is the first listed.
NCT01124045 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01124045 about?
NCT01124045 is a clinical study titled "Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery". The primary objective of this study was to compare the safety and efficacy of Durezol™ compared to Pred Forte™ for the treatment of inflammation following cataract surgery in a pediatric population 0 to 3 years of age.
What is the current status of trial NCT01124045?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 80 participants. The study started on 2010-08. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01124045?
The interventions under investigation include: Difluprednate ophthalmic emulsion, 0.05% (DRUG), Prednisolone acetate ophthalmic suspension, 1.0% (DRUG).
Who is sponsoring clinical trial NCT01124045?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.